AB Artea bankas (VSE:ROE1L)

Market Cap	534.83M
Revenue (ttm)	199.80M
Net Income (ttm)	67.69M
Shares Out	649.86M
EPS (ttm)	0.10
PE Ratio	8.18
Forward PE	8.66
Dividend	0.06 (7.48%)
Ex-Dividend Date	Apr 11, 2025

Volume	424,857
Average Volume	262,061
Open	0.8200
Previous Close	0.8150
Day's Range	0.8150 - 0.8270
52-Week Range	0.7000 - 1.0060
Beta	0.59
RSI	47.82
Earnings Date	Jul 30, 2025

About Theseus Pharmaceuticals

AB Artea bankas, together with its subsidiaries, provides commercial banking products and services to private and corporate customers in Lithuania. It operates through Corporate; Private; and Investment segments. The company offers various deposits; debit and credit cards; consumer, secured, mortgage, multi-apartment house renovation, and short- and long-term loans, as well as credits for farmers and credits with structural instruments; and savings and investment products. It also provides payment, cash operations, trade finance, car and operat...

• Industry: Commercial Banks
• Founded: 1992
• Employees: 1,239
• Stock Exchange: Nasdaq Vilnius
• Ticker Symbol: ROE1L

Financial Performance

In 2024, AB Artea bankas's revenue was 212.82 million, an increase of 17.44% compared to the previous year's 181.22 million. Earnings were 78.79 million, an increase of 4.53%.